Search results

...gene therapy (HSV-tk), interferon gene therapy (TR002 Phase 3), oncolytic virotherapy (ONCOS-102), tumor suppressor replacement (TUSC2/Reqorsa), CRISPR research, ...othelioma, interferon gene therapy, TR002 phase 3, ONCOS-102 mesothelioma, oncolytic virus mesothelioma, TUSC2 Reqorsa, adenovirus gene therapy, Daniel Sterman, ...